A health technology company that makes the world’s smallest heart pump is expanding its Danvers headquarters, which is expected to create more than 100 new jobs, according to the company’s CEO.
“We’ve been very fortunate that the company has a product that has become the standard of care,” said Mike Minogue, CEO of Abiomed. “We want to celebrate our success and prepare for future success by expanding the manufacturing capacity.”
The expansion, which Minogue said will cost more than $5 million over the next five to 10 years, will include an additional 85,000 square feet of space, which the company will lease in a building adjacent to its headquarters. The company has about 600 employees, half of whom work in-state.
The expansion will be announced by Minogue and Gov. Charlie Baker at the company’s headquarters today.
The announcement comes on the heels of recent approval by the Food and Drug Administration for two of Abiomed’s products, including the Impella 2.5 System, a tiny device that helps stabilize heart function during high-risk procedures.
Beth Israel Deaconess Medical Center cardiologist Dr. Duane Pinto, who will accompany Baker and Minogue for the announcement, said the Impella — named for its spinning propeller that keeps blood flowing — “provides much more support for the heart than we previously had.”
About 100,000 cardiac patients in the United States are turned down for heart surgery every year because it’s too risky, and the Impella 2.5 helps reduce that risk, according to an Abiomed statement.
